| 6 7 SELECT MEDICAL 2021 ANNUAL REPORT IMPROVING QUALITY OF LIFE FINANCIAL HIGHLIGHTS SELECT MEDICAL HOLDINGS CORPORATION (In thousands, except per share data) 2021 2020 2019 2018 2017 FOR THE YEARS ENDED Revenue $ 6,204,515 $ 5,531,713 $ 5,453,922 $ 5,081,258 $ 4,365,245 Income from operations 713,774 567,657 471,881 417,279 355,878 Net income attributable to Select Medical Holdings Corporation 402,225 258,995 148,449 137,840 177,184 Earnings per common share, fully diluted 2.98 1.93 1.10 1.02 1.33 Dividends per share 0.375 – – – – Cash flow from operations 401,228 1,028,073 445,182 494,194 238,131 SEGMENT INFORMATION Revenue Critical illness recovery hospital $ 2,246,772 $ 2,077,499 $ 1,836,518 $ 1,753,584 $ 1,725,022 Rehabilitation hospital 849,340 734,673 670,971 583,745 509,108 Outpatient rehabilitation 1,084,361 919,913 1,046,011 995,794 960,902 Concentra 1,732,041 1,501,434 1,628,817 1,557,673 1,013,224 Other 292,001 298,194 271,605 190,462 156,989 Total Revenue $ 6,204,515 $ 5,531,713 $ 5,453,922 $ 5,081,258 $ 4,365,245 Adjusted EBITDA(1) Critical illness recovery hospital $ 267,993 $ 342,427 $ 254,868 $ 243,015 $ 252,679 Rehabilitation hospital 184,704 153,203 135,857 108,927 90,041 Outpatient rehabilitation 138,275 79,164 151,831 142,005 132,533 Concentra(2) 389,616 252,892 276,482 251,977 157,561 Other(2) (33,229) (27,120) (108,130) (100,769) (94,822) Total Adjusted EBITDA $ 947,359 $ 800,566 $ 710,908 $ 645,155 $ 537,992 BALANCE SHEET SNAPSHOT AT YEAR-END Cash and cash equivalents $ 74,310 $ 577,061 $ 335,882 $ 175,178 $ 122,549 Working capital (3) (133,638) 155,634 298,712 287,338 315,423 Total assets (3) 7,360,171 7,655,399 7,340,288 5,964,265 5,127,166 Total debt 3,573,957 3,402,019 3,445,110 3,293,381 2,699,902 Stockholders’ equity 1,109,981 1,060,480 770,972 803,042 823,368 (1) Adjusted EBITDA is used by Select Medical to report its segment performance. Adjusted EBITDA is defined as earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, acquisition costs associated with U.S. HealthWorks, gain (loss) on sale of businesses, and equity in earnings (losses) of unconsolidated subsidiaries. Refer to Item 7 for further consideration of Adjusted EBITDA as a Non-GAAP measure. (2) For the years ended December 31, 2020 and 2021, Select Medical recognized payments received under the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, for health care related expenses and lost revenues attributable to COVID-19 as other operating income. For the year ended December 31, 2020, $88.9 million and $1.1 million of other operating income is included within the operating results of Select Medical’s other activities and Concentra segment, respectively. For the year ended December 31, 2021, $89.1 million and $34.7 million of this other operating income is included within the operating results of Select Medical’s other activities and Concentra segment, respectively. (3) As of December 31, 2019, 2020, and 2021, the balance sheet data reflects the adoption of ASC Topic 842, Leases, which required the recognition of operating lease right-of-use assets and operating lease liabilities on the balance sheet. Prior periods were not adjusted. BOARD of DIRECTORS EXECUTIVE OFFICERS CORPORATE INFORMATION Robert A. Ortenzio Executive Chairman & Co-Founder Select Medical Holdings Corporation Katherine R. Davisson Financial Services Executive James S. Ely III Thomas A. Scully General Partner Welsh, Carson, Anderson & Stowe Rocco A. Ortenzio Vice Chairman & Co-Founder Select Medical Holdings Corporation Founder & Chief Executive Officer PriCap Advisors, LLC William H. Frist Marilyn B. Tavenner Former Administrator of Centers for Medicare & Medicaid Services Russell L. Carson Co-Founder Welsh, Carson, Anderson & Stowe Former Majority Leader of the United States Senate Partner, Cressey & Company Daniel J. Thomas Former Healthcare Executive Bryan C. Cressey Founder & Partner Cressey & Company Parvinderjit Singh Khanuja Founder and Managing Partner of Ironwood Physicians, PC Robert A. Ortenzio Executive Chairman & Co-Founder Martin F. Jackson Executive Vice President & Chief Financial Officer Thomas P. Mullin Executive Vice President, Hospital Operations Rocco A. Ortenzio Vice Chairman & Co-Founder John A. Saich Executive Vice President & Chief Administrative Officer Scott A. Romberger Senior Vice President, & Chief Accounting Officer David S. Chernow President & Chief Executive Officer Michael E. Tarvin Executive Vice President, General Counsel & Secretary Robert G. Breighner, Jr. Vice President, Compliance and Audit Services & Corporate Compliance Officer Corporate Headquarters Select Medical Holdings Corporation 4714 Gettysburg Road Mechanicsburg, PA 17055-5036 717.972.1100 Stockholder Inquiries Joel T. Veit Senior Vice President & Treasurer 4714 Gettysburg Road Mechanicsburg, PA 17055-5036 717.972.1100 | ir@selectmedical.com Register & Stock Transfer Agent Stockholder correspondence should be mailed to: Computershare P.O. Box 505000 Louisville, KY 40233-5000 Independent Registered Public Accounting Firm PricewaterhouseCoopers LLP Two Commerce Square 2001 Market Street, Suite 1800 Philadelphia, Pennsylvania 19103-7042 Stock Exchange NYSE Symbol: SEM Internet Address selectmedicalholdings.com Overnight correspondence should be mailed to: Computershare 462 South 4th Street, Suite 1600 Louisville, KY 40202 |